ONCOURSE Trademark

Trademark Overview


On Wednesday, October 21, 2020, a trademark application was filed for ONCOURSE with the United States Patent and Trademark Office. The USPTO has given the ONCOURSE trademark a serial number of 90268428. The federal status of this trademark filing is REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED as of Tuesday, February 13, 2024. This trademark is owned by Oncopeptides AB. The ONCOURSE trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Pharmaceutical support programs providing patients, patient caregivers and healthcare professionals with pharmaceutical information and advice; providing medical services via telephone and websites in the field of oncology; providing healthcare information, healthcare advice and patient support in the nature of providing information to patients in the field of the treatment and management of hematological diseases, cancer, neoplastic diseases and multiple myeloma; charitable services, namely, a patient assistance program to provide drugs free of charge to uninsured or underinsured patients; all of the aforesaid services being in the field of difficult-to-treat hematological diseases, cancer, neoplastic diseases and multiple myeloma
oncourse

General Information


Serial Number90268428
Word MarkONCOURSE
Filing DateWednesday, October 21, 2020
Status654 - REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED
Status DateTuesday, February 13, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Pseudo MarkON COURSE
Goods and ServicesPharmaceutical support programs providing patients, patient caregivers and healthcare professionals with pharmaceutical information and advice; providing medical services via telephone and websites in the field of oncology; providing healthcare information, healthcare advice and patient support in the nature of providing information to patients in the field of the treatment and management of hematological diseases, cancer, neoplastic diseases and multiple myeloma; charitable services, namely, a patient assistance program to provide drugs free of charge to uninsured or underinsured patients; all of the aforesaid services being in the field of difficult-to-treat hematological diseases, cancer, neoplastic diseases and multiple myeloma

Classification Information


International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, December 9, 2020
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameOncopeptides AB
Party Type10 - Original Applicant
Legal Entity Type09 - Joint Stock Company
AddressStockholm SE-11153
SE

Trademark Events


Event DateEvent Description
Tuesday, February 13, 2024REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, August 16, 2023REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, January 30, 2023REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, May 27, 2022REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, October 22, 2021NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, October 22, 2021LETTER OF SUSPENSION E-MAILED
Friday, October 22, 2021SUSPENSION LETTER WRITTEN
Wednesday, September 22, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, September 21, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 21, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, March 23, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, March 23, 2021NON-FINAL ACTION E-MAILED
Tuesday, March 23, 2021NON-FINAL ACTION WRITTEN
Monday, March 22, 2021ASSIGNED TO EXAMINER
Wednesday, December 9, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, October 24, 2020NEW APPLICATION ENTERED